Paraphrase the text
When starting or ending treatment with omeprazole, the potential for interactions with drugs metabolised through CYP2C19 should be considered.
The ability to interact to medicinal products metabolised by CYP2C19 should be taken into account when initiating or discontinuing omeprazole therapy.